14305 results for ""Pennsylvania+German"+ACS+study+'Socius'+open+access"

in 12.75 milliseconds.

• Data Access Committee

  Dac EGAC00001002967

• Data Access Commitee

  Dac EGAC00001002970

• BilMBG Data Access Committee

  Dac EGAC01000000008

• MolPAGE Data Access Committee

  Dac EGAC01000000017

• NalaGenetics Data Access Committee

  Dac EGAC00001003475

• Wits Data Access Committee

  Dac EGAC00001003520

• UKHD Data Access Committee

  Dac EGAC00001003607

• PGP Data Access Committee

  Dac EGAC00001003587

• Whole exome sequencing (WES) of EBV- primary central nervous system lymphoma (PCNSL)

  This dataset contains whole exome sequencing (WES) of 29 HIV- EBV- primary central nervous system lymphoma (PCNSL) tumors and 5 activated B-cell-like PCNSL (ABC-PCNSL) and activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) cell lines (TK, HKBML, OCI-Ly3, HBL-1, TMD-8). Cases with secondary involvement of the CNS were excluded. DNA was extracted with AllPrep DNA/RNA FFPE kit and libraries were prepared using the Agilent SureSelect Human All Exon v6 + UTR kit. Paired end reads were aligned to GRCh37 using bwa mem v.0.7.17, and reads were sorted and duplicated were marked in the final BAM files. Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

  Dataset EGAD50000000451

• HELIUS DAC The HELIUS data are owned by the Amsterdam University Medical Centers, location AMC in Amsterdam, The Netherlands. To allow sharing of microbiome data collected in HELIUS with (inter)national researchers, 16s rRNA sequence analysis has been stored at the European genome-phenome archive (EGA; accession code EGAD00001004106). This requires that access needs to be granted, also because the HELIUS data are stored with relevant phenotypical variables. Access is granted to all researchers affiliated with an internationally recognized research institution who request to use the HELIUS data within the EGA context, after having signed the data transfer agreement. Any researcher can request the data by submitting a proposal to the HELIUS Executive Board as outlined at http://www.heliusstudy.nl/en/researchers/collaboration, by email: heliuscoordinator at amsterdamumc dot nl. The HELIUS Executive Board will check proposals if they do not conflict with ethical approvals and informed consent forms of the HELIUS study.

  Dac EGAC00001000895

• Haukeland University Hospital Data Access Committee for ParkOme-1 datasets archvied in Federated EGA Norway

  Data Access Committee appointed by Haukeland University Hospital for omics datasets for Parkinson's disease and related disorders, generated in studies under the ParkOme-1 project. Omics datasets of different types are generated from fresh frozen brain tissue from individuals with neurodegenerative parkinsonisms and neurologically healthy controls.

  Dac EGAC50000000193

• HELIUS cohort

  The gut microbiota composition is unique to every individual but is shaped by common factors including diet, lifestyle, medication use, early-life determinants, living environment or genetics. Most of these factors may be influenced by ethnicity. This study explored variations in fecal microbiota composition in 6048 individuals with different ethnic backgrounds living in the same geographical area (Amsterdam, the Netherlands). The HELIUS data are owned by the Amsterdam University Medical Centers, location AMC in Amsterdam, The Netherlands. To allow sharing of microbiome data collected in HELIUS with (inter)national researchers, 16s rRNA sequence analysis has been stored at the European genome-phenome archive (EGA; accession code EGAD00001004106). This requires that access needs to be granted, also because the HELIUS data are stored with relevant phenotypical variables. Access is granted to all researchers affiliated with an internationally recognized research institution who request to use the HELIUS data within the EGA context, after having signed the data transfer agreement. Any researcher can request the data by submitting a proposal to the HELIUS Executive Board as outlined at http://www.heliusstudy.nl/en/researchers/collaboration, by email: heliuscoordinator at amsterdamumc dot nl. The HELIUS Executive Board will check proposals if they do not conflict with ethical approvals and informed consent forms of the HELIUS study.

  Study EGAS00001002969

• Link to the Finnish FEGA Node's service provider

  We would like to direct you to the service provider for the Finnish FEGA Node, which is CSC – IT Center for Science (https://research.csc.fi/-/fega). It's important to note that this is not a genuine DAC and does not serve as the data controller. To obtain access to data stored in FI-FEGA, it is essential to utilize the local access management system SD Apply. Please be aware that applications submitted through the EGA DAC portal will not be processed. For a seamless experience, we kindly request you to refer to the policy of your selected dataset and submit your access application through SD Apply (https://sd-apply.csc.fi/). Your cooperation is highly appreciated.

  Dac EGAC50000000022

• RNA-seq data of proliferative vitreoretinal diseases and healthy human retinal pigment epithelium

  This Data Access Committee (DAC) evaluates access requests for RNA-seq data generated from: - Membranes from proliferative vitreoretinal diseases, including proliferative vitreoretinopathy and epiretinal membranes. - Retinal pigment epithelial cells isolated from healthy ocular globes obtained from deceased donors. Collection and analysis of these residual human materials were conducted with the approval of the ULB-Erasme Ethical Committee (P2019/066 A2022/136) and of the Eye Bank (CHU Liège), with no need for informed consent in compliance with Belgian law. All data are pseudonymised, and access is restricted to qualified researchers whose proposed use of the data is consistent with the applicable ethical approval and legal requirements, including the General Data Protection Regulation (GDPR).

  Dac EGAC50000000721

• cfDNA Data Access Committee

  Dac EGAC00001002847

• VIB Data Access Committee

  Dac EGAC00001003263

• Leiomyosarcoma Data Access Committee

  Dac EGAC00001000415

• PRMS Data Access Commitee

  Dac EGAC00001003267

• PBTG Data Access Committee

  Dac EGAC00001002753

• Autopsy data access committee

  Dac EGAC00001002884

• TEP data access committee

  Dac EGAC00001002986

• Neuroblastoma Data Access Committee

  Dac EGAC00001000085

• HRD Data Access Committee

  Dac EGAC00001003219

• DEFLeCT data access team

  Dac EGAC00001003225

• LYMPHGEN Data Access Commitee

  Dac EGAC00001003229

• Sarcoma Data Access Committee

  Dac EGAC00001003226

• CIBIO Data Access Commitee

  Dac EGAC00001003097

• RIMLS-Science access committee

  Dac EGAC00001003333

• DIAMONDS Data Access Committee

  Dac EGAC00001003339

• IgA Neuropathy Data Access Committee

  Dac EGAC00000000013

• MELARISK Data Access Committee

  Dac EGAC00000000016

• CENet data access commitee

  Dac EGAC00001003396

• Carcinosarcoma Data Access Committee

  Dac EGAC00001000234

• YM Data Access Committee

  Dac EGAC00001000343

• Somatotropinoma Data Access Committee

  Dac EGAC00001000353

• UTSW Data Access Committee

  Dac EGAC00001000494

• EUROTAST Data Access Committee

  Dac EGAC00001000687

• NJLCC Data Access Commitee

  Dac EGAC00001000886

• SCPC Data Access Committee

  Dac EGAC00001000914

• SH-ACTHPA Data Access Committee

  Dac EGAC00001000919

• AUBTRG Data Access Commitee

  Dac EGAC00001000926

• Bajau Data Access Committee

  Dac EGAC00001000967

• TGen Data Access Commitee

  Dac EGAC00001000973

• IPCGS Data Access Committee

  Dac EGAC00001001014

• CSF sWGS data access comittee

  Dac EGAC00001001037

• TAHSU Data Access Commitee

  Dac EGAC00001001098

• HNSCI Data Access Committee

  Dac EGAC00001001100

• AMC Macrophage Data Access Committee

  Dac EGAC00001001123

• EPICOLON2 Data Access Commitee

  Dac EGAC00001001190

• Amazentis Data Access Commitee

  Dac EGAC00001001195